EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cannabinoids and the endocannabinoid system in liver diseases

Anna Parfieniuk-Kowerda, Diana Martonik, Aleksandra Andrzejuk, Aleksander Tarasik, Robert Flisiak

Clinical and Experimental Hepatology · 2024 · 10 (4) · 211-217

DOI: 10.5114/ceh.2024.145358 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Hepatology, 2024. Verfasst von Anna Parfieniuk-Kowerda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabinoids are biologically active substances acting via feedback-coupled CB1 and CB2 receptors. Their expression in myofibroblasts and liver endothelial cells is reported to be elevated in chronic liver diseases. The effect of CB1 receptor stimulation is to increase fibrosis and inflammatory activity in the liver by stimulating stellate cells, while activation of the CB2 receptor results in inhibition of fibrosis. Stimulation of the CB1 receptor may also lead to progression of liver steatosis and carcinogenesis. In end-stage liver disease, the endocannabinoid system plays an important role in the pathogenesis of encephalopathy and vascular effects, such as portal hypertension, splanchnic vasodilatation and cirrhotic cardiomyopathy. It seems that interference in endocannabinoid transmission may serve as an attractive target for the development of hepatological drugs.

Schlagwörter

Stichwörter der Autor:innen

CB1CB2cannabinoidsendocannabinoidsliver diseases

Autor:innen und Institutionen

  • Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland.
  • Faculty of Medicine, Medical University of Białystok, Białystok, Poland.
  • Colorectal Cancer Unit, Maria Sklodowska-Curie Bialystok Oncology Centre, Białystok, Poland.

Zitieren

APA

Parfieniuk-Kowerda, A., Martonik, D., Andrzejuk, A., Tarasik, A., & Flisiak, R. (2024). Cannabinoids and the endocannabinoid system in liver diseases. Clinical and Experimental Hepatology, 10(4), 211-217. https://doi.org/10.5114/ceh.2024.145358

Vancouver

Parfieniuk-Kowerda A, Martonik D, Andrzejuk A, Tarasik A, Flisiak R. Cannabinoids and the endocannabinoid system in liver diseases. Clinical and Experimental Hepatology. 2024;10(4):211-217. doi:10.5114/ceh.2024.145358

BibTeX
@article{ParfieniukKowerda2024,
  author = {Parfieniuk-Kowerda, Anna and Martonik, Diana and Andrzejuk, Aleksandra and Tarasik, Aleksander and Flisiak, Robert},
  title = {Cannabinoids and the endocannabinoid system in liver diseases},
  journal = {Clinical and Experimental Hepatology},
  year = {2024},
  volume = {10},
  number = {4},
  pages = {211--217},
  doi = {10.5114/ceh.2024.145358}
}
Kostenlos starten →